Medibyt

Company Overview

Snapshot

Founded in May 2024 by Or Inbar and Niv Caspi, Medibyt operates with 1–10 employees. The company has secured funding across two rounds, with a notable grant received in August 2024.

Business overview

Medibyt provides an AI-powered platform designed for the interpretation of cardiopulmonary exercise testing (CPET), aiming to automate analysis and streamline clinical workflows. Its flagship product, CPETWise, processes complex physiological data to generate structured, clinician-ready reports rapidly. This cloud-based solution is compatible with existing metabolic systems, supports remote diagnostics, and integrates into various healthcare settings, serving the Health Tech & Life Sciences sector, particularly in digital healthcare and medical decision support.

Strategic signal

In March 2025, research published in the European Journal of Applied Physiology highlighted the paradigm shift towards comprehensive medical evaluation of exercise function, specifically referencing the transition from stress electrocardiograms to cardiopulmonary exercise testing. This underscores the growing market relevance and clinical adoption of CPET, validating Medibyt's focus on AI-driven interpretation in this evolving diagnostic landscape and signaling strong future demand for its CPETWise platform.

Company Intelligence Q&A

When was Medibyt founded and by whom?

Medibyt was founded in May 2024 by co-founders Or Inbar and Niv Caspi.

What is Medibyt's primary product?

Medibyt's primary product is CPETWise, an AI-powered platform that automates the interpretation of cardiopulmonary exercise test (CPET) data, transforming it into structured reports for clinicians.

What is the core technology behind Medibyt's platform?

Medibyt's platform leverages artificial intelligence and machine learning to interpret complex physiological data from cardiopulmonary exercise tests.

What was a significant recent development in the field of cardiopulmonary exercise testing?

In March 2025, the European Journal of Applied Physiology published an article discussing the transition from stress electrocardiograms to cardiopulmonary exercise testing as a paradigm shift toward comprehensive medical evaluation of exercise function.

What markets does Medibyt target with its solutions?

Medibyt targets healthcare providers in markets including Canada, Europe, North America, and China with its digital healthcare solutions.